US/UK/Canada

Share

Contacts

  • Jonas Wiström

    CEO


    +46 8 700 17 00
  • Josefine Uppling

    VP Communication


    +46 76 114 54 21

    • Links

    Pick a time period -
    Tags ( Active)

    Ratos Company TFS HealthScience acquires Appletree CI Group

    TFS HealthScience (TFS), a global contract research organization (CRO), acquires Appletree CI Group (Appletree) to enhance the company’s existing expertise in the complex fields of ophthalmology, medical devices, and pediatric studies, simultaneously expanding geographic reach for clients.Appletree CI Group was founded in 2013. The company is focused on five primary business areas; in addition to ophthalmology and medical devices, they have expertise in the fields of dermatology, pediatric trials, and regulatory affairs.   Ophthalmology is a rapidly growing field of medicine, with

    Ratos company TFS HealthScience expands – opens new North American office

    TFS HealthScience (TFS) is continuing to grow. Today, the company is opening its new US headquarters at the Research Triangle Park in Durham, North Carolina (NC). As the centre for funding of biotech and pharma studies, the US market is a prioritised growth market for TFS.“With the opening of our new US headquarters, we are able to further improve our global offering. TFS operates globally and our new office marks a milestone in our growth journey. The opening will strengthen our US presence, a growing market that today represent 30% of the company’s total sales. I am very excited about

    TFS enters partnership in the US with the Duke Clinical Research Institute

    TFS has entered into a strategic partnership with the Duke Clinical Research Institute (DCRI) in North Carolina, US, to provide data management solutions in clinical trials.The unique collaboration expands TFS’s capability to execute clinical trials for both commercial and government sponsors in the U.S. It supports the company’s growth strategy and further develops its scientific offering. Duke Clinical Research Institute is a world-renowned research institute, recognized for bringing innovation to clinical trial design and execution. “DCRI is known for ushering in new and innovative

    TFS in partnership to conduct a global study on COVID-19 pandemic

    TFS forms a partnership to conduct a real-world evidence study on COVID-19 pandemic to inform decision-makers.As the COVID-19 pandemic continues to spread there is an increased need to analyse real-world evidence for prioritized questions shared by national governments and public health agencies. TFS partners with Observational Health Data Sciences and Informatics (OHDSI) for the study, where TFS role will be to analyse the data that is collected from several Spanish Hospitals. Analysing real world evidence, enables TFS to help inform decisionmakers using up to date information and

    Bassem Saleh appointed new CEO of TFS

    Bassem Saleh has been appointed new CEO of TFS. Bassem is Chief Medical Officer at TFS and Executive Vice President of Clinical Development Services, the largest Business Area at TFS. He will assume his role as CEO today, 17 December. János Filakovský is stepping down from his position as CEO and leaving the company.Bassem Saleh has solid executive leadership skills and long industry experience from both CROs (Contract Research Organisations) and Biopharma including Premiere Research, ICON, PRAHS and Chugai (Roche group). Most recently Bassem has been heading up TFS largest Business Area

    There are no items matching the current filter
    There are no more items matching the current filter
    Back to top

    Subscribe

    Media